The Latest Cardiac and Vascular News
CHICAGO, May 6, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) awarded grants to three researchers its 2022 Annual Meeting. ISHLT grants fund research to improve the care of patients with advanced heart and lung disease through transplantation, mechanical circulatory support (MCS), and innovative therapies. “I am absolutely […]
Results from the DELIVER and DAPA-HF Phase III trials demonstrate FARXIGA’s efficacy in heart failure regardless of ejection fraction WILMINGTON, Del.–(BUSINESS WIRE)–High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a statistically significant and clinically meaningful reduction in the primary composite endpoint of cardiovascular (CV) death or […]
EMERYVILLE, Calif., May 4, 2022 /PRNewswire/ — Discovering new ways to treat heart and lung diseases by tapping into the natural disease resistance of hibernating animals is the focus of a new partnership between Monash University and Fauna Bio, a U.S. biotechnology company. Hibernation requires mechanisms of self-healing and tissue repair to endure […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ biopolymer surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – LifePolymer™ – with an […]
NEW YORK, May 3, 2022 /PRNewswire/ — Medscape Education and the American College of Cardiology (ACC) will collaborate in 2022 to implement an ACC-dedicated collection page on Medscape.org with two new Continuing Medical Education (CME) initiatives for lipid management and cardiovascular (CV) risk reduction. This collaboration will combine ACC and Medscape’s strengths in learning […]
The latest prespecified and post hoc sub-analysis of the landmark REDUCE-IT® study, published today in the Journal of the American College of Cardiology (JACC), demonstrated that VASCEPA® (icosapent ethyl) significantly reduces the total ischemic event risk of cardiovascular death, stroke, myocardial infarction (heart attack), coronary revascularization, or hospitalization for unstable angina by 35% […]
MONTREAL, May 03, 2022 (GLOBE NEWSWIRE) — As the National Heart Failure Awareness Week begins, the Montreal Heart Institute announces the creation of the Canadian Heart Function Alliance (CHF Alliance) Network. Uniting an extensive network of researchers, cardiologists, patients, caregivers, Indigenous elders, policymakers and supporting organizations across the country, this […]
PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device manufacturer that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, today announced the authorization by the French National Agency for the Safety of Medicines and Health Products to proceed with a […]
American Heart Association consortium advances development of evidence-based health tech solutions PLEASANTON, Calif., May 3, 2022 /PRNewswire/ — Movano, a healthcare solutions company at the intersection of medtech and consumer devices, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building […]
EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population Medtronic today announced the first patient enrollment in the EXPAND TAVR II Pivotal Trial, the first randomized clinical trial evaluating the self-expanding, supra-annular Evolut™ TAVR platform in patients with moderate, symptomatic aortic stenosis (AS), a […]
